Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older Pharmaceutical Investing
VUITY 1.25%, the First and Only FDA-Approved Eye Drop to Treat Age-Related Blurry Near Vision , is Now Available Pharmaceutical Investing
BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium® Life Science Investing
BetterLife Obtains Positive TD-0148A Data in Preclinical Models of Depression Pharmaceutical Investing
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS for the Treatment of Adults With Active Lupus Nephritis Pharmaceutical Investing
Cloud DX's Post-Surgical Monitoring Wearable Validated in Peer-Reviewed Study Medical Device Investing
Lexaria's DehydraTECH-CBD Reduces Arterial Stiffness, Results Confirmed in Human Clinical Study HYPER-H21-2 Company News
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
